Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ME - 23andMe Holding Co.

IEX Last Trade
3.28
0.130   3.963%

Share volume: 6,002
Last Updated: Fri 27 Dec 2024 08:30:20 PM CET

PREVIOUS CLOSE
CHG
CHG%
$3.15
0.13
4.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.56%
1 Month
3.82%
3 Months
1,008.47%
6 Months
676.19%
1 Year
261.54%
2 Year
58.25%
Key data
Stock price
$3.28
P/E Ratio 
-0.17
DAY RANGE
$3.10 - $3.33
EPS 
-$1.30
52 WEEK RANGE
$0.29 - $5.50
52 WEEK CHANGE
$256.87
MARKET CAP 
106.909 M
YIELD 
N/A
SHARES OUTSTANDING 
339.503 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.65
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$216,996
AVERAGE 30 VOLUME 
$272,760
Company detail
CEO: Anne E. Wojcicki
Region: US
Website: 23andme.com
Employees: 770
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The company was founded in 2006 and is headquartered in South San Francisco, California.

Recent news